Actively Recruiting
A Registered Cohort Study on FSHD1
Led by Ning Wang, MD., PhD. · Updated on 2024-08-26
1000
Participants Needed
1
Research Sites
1613 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The data to be collected is intended to help healthcare providers make important medical and financial decisions concerning FSHD1, through an enhanced understanding of the prevalence, progression and natural history of FSHD1.
CONDITIONS
Official Title
A Registered Cohort Study on FSHD1
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female subjects of all ages at baseline
- Subjects, with or without symptoms, with FSHD1 genetic confirmation through PFGE-based Southern blotting
- Unrelated healthy controls
You will not qualify if you...
- Decline to participate
- Other neuromuscular disease such as Limb-girdle muscular dystrophy or Myotonic dystrophy
- Serious systemic illness such as heart, liver, kidney disease or major mental illness
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China, 350005
Actively Recruiting
Research Team
N
Ning Wang
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here